PLI.TO (CA74342Q1046)
ProMetic Life Sciences Inc. (ProMetic) is a bio-pharmaceutical company offering technologies for large-scale drug purification, drug development, proteomics, clinical diagnostics, and the elimination of pathogens
MARKET: Toronto
Fair value: CAD 3.2
Discount: 9%
Average annual return: 40%
Outperformer
August 11, 2016
PLI announces 16Q2:
Qtrly net loss of $24.6 million
during quarter ended June 30, 2016 compared to a net loss of $13.5 million Q2 revenue C$3.3 million versus C$2.9 million
ProMetic Life Sciences Inc. (ProMetic) is a bio-pharmaceutical company offering technologies for large-scale drug purification, drug development, proteomics, clinical diagnostics, and the elimination of pathogens
MARKET: Toronto
Fair value: CAD 3.2
Discount: 9%
Average annual return: 40%
Outperformer
August 11, 2016
PLI announces 16Q2:
Qtrly net loss of $24.6 million
during quarter ended June 30, 2016 compared to a net loss of $13.5 million Q2 revenue C$3.3 million versus C$2.9 million
No comments:
Post a Comment